Back to MW MARSHALL WACE, LLP

ONCYONCY
2 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ONCOLYTICS BIOTECH INC

Yes. Marshall Wace holds 745,350 shares of ONCY (Oncolytics Biotech), worth $708,082, as of its Q2 2026 13F filing. It reduced the position by 114,481 shares (-13.3%) from Q1 2026. Marshall Wace has held ONCY since Q1 2026, across 2 quarterly 13F filings.

Current Value

$708,082

Current Shares

745,350

Total Value Change

-$22,777

Total Shares Change

-114,481

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
745,350
-13.3%
$708,0820.0%$0.95
0
2026-Q1
New
859,831
-
$730,8590.0%$0.85
34

Other major holders of ONCY: XTX Topco Ltd, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, HRT FINANCIAL LP, Invesco Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used